Genotyping and Clinicoepidemiological Characterization of Rotavirus Acute Gastroenteritis in Egyptian Children

Publications

Share / Export Citation / Email / Print / Text size:

Polish Journal of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 1733-1331
eISSN: 2544-4646

DESCRIPTION

8
Reader(s)
19
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 65 , ISSUE 4 (December 2016) > List of articles

Genotyping and Clinicoepidemiological Characterization of Rotavirus Acute Gastroenteritis in Egyptian Children

Niveen Saudy * / Walaa Othman Elshabrawy / Ahmed Megahed / Mona F. Foad / Aly F. Mohamed

Keywords : gastroenteritisin in children, RVA genotypes, clinicoepidemiological characterization in Egypt.

Citation Information : Polish Journal of Microbiology. Volume 65, Issue 4, Pages 433-442, DOI: https://doi.org/10.5604/17331331.1227669

License : (CC BY-NC-ND 4.0)

Received Date : 27-November-2015 / Accepted: 18-April-2016 / Published Online: 28-December-2016

ARTICLE

ABSTRACT

Group A rotavirus (RVA) acute gastroenteritis (AGE) is a common cause of severe childhood diarrhea. The dominant circulating RVA genotypes in a given region may vary between and within the geographic regions and from year to year. Our cross-sectional study was designed to determine the burden of RVA genotypes among children with AGE admitted to referral Children Hospital at Egypt prior to implementation of the vaccine. Stool samples with clinico-epidemiological data were collected from 92 children ≤ 3 years-old with AGE. RVA G and P typing were performed with type-specific primers. RVA was detected in 48.9% of patients. Higher rates of RVA infections, 73.3% were detected in infants < 1 year-old. Breast-fed infants were significantly fewer in RVA positive group (P = 0.0006). Non-breast­feeding was a major risk factor for RVA AGE (OR 0.3, P = 0.02). RVA diarrhea occurred mostly in autumn and winter months (55.4% and 26.6%) with a significant difference in autumn (P = 0.0005) and was associated with vomiting and dehydration (OR; 1.66, P = 0.021 & 1.4, P = 0.03). RVA genotypes G1P[8] (26.7%), G9P[8] (20%) and G3P[8] (15.6%) were accounting for 62.3% of RVA AGE. G9 was significantly associated with mucus diarrhea, than G1 or G3 which were associated with watery diarrhea (P = 0.025). Also, G9 was significantly associated with loose stool for > 5 days (P = 0.006) and 54.4% of G9 patients had severe dehydration. The diversity of RVA strains detected in Nile Delta Egypt and emergence of G9 RVA highlight the need to apply vaccines against this genotype in Egypt.

Content not available PDF Share

FIGURES & TABLES

REFERENCES

Agócs M.M., F. Serhan, C. Yen, J.M. Mwenda, L.H. de Oliveira, N. Teleb, A. Wasley, P.R. Wijesinghe, K. Fox, J.E. Tate and others. 2014. WHO global RVA surveillance network: a strategic review of the first 5 years, 2008–2012. MMWR 25. 63(29): 634–637.

 

Amer M.A., S.M. Abdel Salam, H.A. Ibrahim and M.A. Farag. 2007. Detection of group A Rota virus and characterization of G type among Egyptian children with diarrhea. Egyptian J. Med. Microbiol. 16(1): 123–132.

 

Bahl R., P. Ray, S. Subodh, P. Shambharkar, M. Saxena, U. Parashar, J. Gentsch, R. Glass, M.K. Bhan and Delhi Rotavirus Study Group. 2005. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J. Infect. Dis. 192(Suppl 1): S114–S119.

 

Cao D., M. Barro and Y. Hoshino. 2008. Porcine RVA bearing an aberrant gene stemming from an intergenic recombination of the NSP2 and NSP5 genes is defective and interfering. J. Virol. 82: 6073–6077.

 

Chouikha A., I. Fodha, S. Noomen, L. Bouzid, M. Mastouri,I. Peenze, M. De Beer, J. Dewar, A. Geyer, T. Sfar and others. 2007. Group A RVA strains circulating in the eastern center of Tunisia dur-ing a ten-year period (1995–2004). J. Med. Virol. 79(7): 1002–1008.

 

DiStefano D.J., N. Kraiouchkine, L. Mallette, M. Maliga, G. Kul¬nis, P.M. Keller, H.F. Clark and A.R. Shaw. 2005. Novel RVA VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J. Clin. Microbiol. 43(12): 5876–5880.

 

El-Senousy W.M. and E.M. El-Mahdy. 2009. Detection and geno¬typing of RVAes in water treatment plants of El-Dakahlia Governorate. Egyp. J. Biotechnol. 31: 25–34.

 

El-Senousy W.M., Y.E. Shahein, A.B. Barakat, H.E. Ghanem,A.E. El-Hakim and S.M. Ameen. 2013. Molecular cloning and immunogenicity evaluation of RVA structural proteins as candidate vaccine. Int. J. Biol. Macromol. 59: 67–71.

 

Endara P., G. Trueba, O.D. Solberg, S.J. Bates, K. Ponce, W. Ceval¬los, J. Matthijnssens and J.N. Eisenberg. 2007. Symptomatic and subclinical infection with RVA P[8]G9, rural Ecuador. Emerg. Infect. Dis. 13(4): 574–580.

 

Esona M.D., A. Geyer, N. Page, A. Trabelsi, I. Fodha, M. Aminu, V.A. Agbaya, B. Tsion, T.K. Kerin, G.E. Armah and others. 2009. Genomic characterization of human RVA G8 strains from the African RVA network: relationship to animal RVAes. J. Med. Virol. 81(5): 937–951.

 

Espinola E., A. Amarilla, J. Arbiza and G.I Parra. 2008. Sequence and phylogenetic analysis of the VP4 gene of human RVAes isolated in Paraguay. Arch. Virol. 153(6): 1067–1073.

 

Fang Z.Y., H. Yang, J. Qi, J. Zhang, L.W. Sun, J.Y. Tang, L. Ma,Z.Q. Du, A.H. He, J.P. Xie and others. 2002. Diversity of RVA strains among children with acute diarrhea in China: 1998–2000 surveillance study. J. Clin. Microbiol. 40: 1875–1878.

 

Gentsch J.R., R.I. Glass, P. Woods, V. Gouvea, M. Gorziglia,J. Flores, B.K. Das and M.K. Bhan. 1992. Identification of group A RVA gene 4 types by polymerase chain reaction. J. Clin Microbiol. 30(6): 1365–1373.

 

Gentsch J.R., A.R. Laird, B. Bielfelt, D.D. Griffin, K. Banyai, M. Ramachandran, V. Jain, N.A. Cunliffe, O. Nakagomi, C.D. Kirk-wood and others. 2005. Serotype diversity and reassortment betweenhuman and animal RVA strains: implications for RVA vaccine pro¬grams. J. Infect. Dis. 192(Suppl 1): S146–159.

 

Gouvea V., R.I. Glass, P. Woods, K. Taniguchi, H.F. Clark, B. For¬rester and Z.Y. Fang. 1990. Polymerase chain reaction amplifica¬tion and typing of RVA nucleic acid from stool specimens. J. Clin. Microbiol. 28(2): 276–282.

 

Gouvea V., L. de Castro, M.C. Timenetsky, H. Greenberg, andN. Santos. 1994. RVA serotype G5 associated with diarrhea in Bra¬zilian children. J. Clin. Microbiol. 32(5): 1408–1409.

 

Hashem S.E., A. Sahar, S.A. Shoman, S.A. Zaki and A.F. Elsayed. 2012. Isolation and molecular genotyping of group A RVA strains circulating among Egyptian infants and children. Austr. J. Basic App. Sci. 6(6): 361–367.

 

Iturriza-Go’mara M., C. Wong, S. Blome, U. Desselberger and J. Gray. 2002. RVA subgroup characterization by restriction endo¬nuclease digestion of a cDNA fragment of the VP6 gene. J. Virol. Meth. 105: 99–103.

 

Kamel A.H., M.A. Ali, H.G. El Nady, A. de Rougemont, P. Pothierand G. Belliot. 2009. Predominance and circulation of enteric viruses in the region of Greater Cairo, Egypt. J. Clin. Microbiol. 47(4): 1037–1045.

 

Kamel A.H., M.A. Ali, H.G. El-Nady, S. Aho and P. Pothier. 2010. Evidence of the co-circulation of enteric viruses in sewage and in the population of Greater Cairo. J. Appl. Microbiol. 108: 1620–1629.

 

Linhares A.C., T. Verstraeten, J. Wolleswinkel-van den Bosch, R. Clemens and T. Breuer. 2006. RVA serotype G9 is associated with more-severe disease in Latin America. Clin. Infect. Dis. 43(3): 312–314.

 

Lovmar L., C. Fock, F. Espinoza, F. Bucardo, A.C. Syvänen andK. Bondeson. 2003. Microarrays for genotyping human group a RVA by multiplex capture and type-specific primer extension. J. Clin. Microbiol. 41(11): 5153–5158.

 

Mandour R.A., A.A. Ghanem and S.M. El-Azab. 2013. Correla¬tion between lead levels in drinking water and mothers’ breast milk: Dakahlia, Egypt. Environ. Geochem. Health 35(2): 251–256.

 

Mansour A.M., M. El Koutby, M.M. El Barbary, W. Mohamed,S. Shehata, H. El Mohammady, M. Mostafa, M.S. Riddle, P.J. Sebeny,S.Y. Young and others. 2013. Enteric viral infections as potential risk factors for intussusception. J. Infect. Dev. Ctries. 15; 7(1): 28–35.

 

Matson D.O., I.A. Abdel-Messih, C.D. Schlett, K. Bok, T. Wienkopff, T.F. Wierzba, J.W. Sanders and R.W.Jr. Frenck. 2010. RVA Genotypes among hospitalized children in Egypt, 2000–2002. J. Infect. Dis. 202(S1): S263–265.

 

Matthijnssens, J.1., M. Ciarlet, E. Heiman, I. Arijs, T. Delbeke, S.M. McDonald, E.A. Palombo, M. Iturriza-Gómara, P. Maes,J.T. Patton and others. 2008. Full genome-based classification of RVAes reveals a common origin between human Wa-Like and por¬cine RVA strains and human DS-1-like and bovine RVA strains.J. Virology 82: 3204–3219.

 

Matthijnssens J., E. Heylen, M. Zeller, M. Rahman, P. Lemey and M. Van Ranst. 2010. Phylodynamic analyses of RVA genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 27(10): 2431–2436.

 

Matthijnssens J., S. De Grazia, J. Piessens, E. Heylen, M. Zeller,G.M. Giammanco, K. Bányai, C. Buonavoglia, M. Ciarlet, V. Mar¬tella and others. 2011. Multiple reassortment and interspecies trans-mission events contribute to the diversity of feline, canine and feline/canine-like human group A RVA strains. Infect. Genet. Evol. 11(6): 1396–1406.

 

Matthijnssens J. and M. Van Ranst. 2012. Genotype constellation and evolution of group A RVAes infecting humans. Curr. Opin. Virol. 2(4): 426–433.

 

Misra S., T.K. Sabui, S. Basu and N. Pal. 2007. A prospective study of RVA diarrhea in children under 1 year of age. Clinical Pediatrics 46(8): 683–688.

 

Mwenda J.M., K.M. Ntoto, A. Abebe, C. Enweronu-Laryea,I. Amina, J. Mchomvu, A. Kisakye, E.M. Mpabalwani, I. Pazvakavambwa, G.E. Armah and others. 2010. Burden and epidemiology of RVA diarrhea in selected African countries: preliminary results from the African RVA Surveillance Network. J. Infect. Dis. 202(Suppl): S5–S11.

 

Naficy A.B., R. Abu-Elyazeed, J.L. Holmes, M.R. Rao, S.J. Savarino,Y. Kim, T.F. Wierzba, L. Peruski, Y.J. Lee, J.R. Gentsch andothers. 1999. Epidemiology of RVA diarrhea in Egyptian children andimplications for disease control. Am. J. Epidemiol. 150(7): 770–777.

 

Ortega O., N. El-Sayed, J.W. Sanders, Z. Abd-Rabou, L. Antil, J. Bresee, A. Mansour, I. Adib, I. Nahkla and M.S. Riddle. 2009. Cost-benefit analysis of a RVA immunization program in the Arab Republic of Egypt. J. Infect. Dis. 200: S92–98.

 

Parashar U.D., C.J. Gibson, J.S. Bresse and R.I. Glass. 2006. RVA and severe childhood diarrhea. Emerg. Infect. Dis. 12: 304–306.

 

Plenge-Bönig A., N. Soto-Ramírez, W. Karmaus, G. Petersen,S. Davis and J. Forster. 2010. Breastfeeding protects against acute gas-troenteritis due to RVA in infants. Euro. J. Ped. 169(12): 1471–1476.

 

Potgieter N., M.C. de Beer, M.B. Taylor and A.D. Steele. 2010. Prevalence and diversity of RVA strains in children with acute diarrhea from rural communities in the Limpopo Province, South Africa, from 1998 to 2000. J. Infect. Dis. 202(Suppl): S148–55.

 

Prameela K.K. and L.R. Vijaya. 2012. The importance of breast¬feeding in rotaviral diarrhoeas. Mal. J. Nutrition. 18(1): 103–111.

 

Prasetyo D., I.M. Sabaroedin, Y.S. Ermaya and Y. Soenarto. 2015. Association between severe dehydration in RVA diarrhea and exclu¬sive breastfeeding among infants at dr. Hasan Sadikin General Hos¬pital, Bandung, Indonesia. J. Trop. Med. ID 862578: 4.

 

Radwan S.F., M.K. Gabr, S. El-Maraghi and A.F. El-Saifi. 1997. Serotyping of group A RVAes in Egyptian neonates and infants less than 1 year old with acute diarrhea. J. Clin. Microbiol. 35(11): 2996–2998.

 

Rahman M., R. Sultana, G. Podder, A.S.G. Faruque, J. Matthijnssens, K. Zaman, R.F. Breiman, D.A. Sack, M. Van Ranst and T. Azim. 2005. Typing of human RVA serotypes: Nucleotide mismatches between the VP7 gene and primer are associated with genotyping failure. Virol. J. 2: 24–29.

 

Santos N. and Y. Hoshino. 2005. Global distribution of RVAserotypes/genotypes and its implication for the development and implementation of an effective RVA vaccine. Rev. Med. Virol. 15: 29–56

 

Santos N., E.M. Volotao, C.C. Soares, G.S. Campos, S.I. Sardi and Y. Hoshino. 2005. Predominance of RVA genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: Implications for future vaccine strategies. J. Clin. Microbiol. 43: 4064–4069.

 

Santos S.M.R., T.L. Ferreira, V.S. Quintal, S.B. Carbonare and M. Tino-De-Franco. 2013. Milk from Brazilian women presents secretory IgA antibodies and neutralizes RVA G9P[5]. J. Ped. 89(5): 510–513.

 

Schael I.P., R. González and B. Salinas. 2009. Severity and age of RVA diarrhea, but not socioeconomic conditions, are associated with RVA seasonality in Venezuela. J. Med. Virol. 81(3): 562–567.

 

Tate J.E., A.H. Burton, C. Boschi-Pinto, A.D. Steele, J. Duque and U.D. Parashar. 2012. WHO-coordinated Global RVA Surveillance Network. 2008 estimate of worldwide RVA-associated mortality in children younger than 5 years before the introduction of universal RVA vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 12(2): 136–41.

 

Than V.T. and W. Kim. 2013. Prevalence of rotavirus genotypes in South Korea in 1989–2009: implications for a nationwide rotavirus vaccine program. Korean J. Pediatr. 56(11): 465–473.

 

Unicomb L.E., G. Podder, J.R. Gentsch, P.A. Woods, K.Z. Hasan, A.S. Faruque, M.J. Albert and R.I. Glass. 1999. Evidence of high--frequency genomic reassortment of group A RVA strains in Bangla-desh: emergence of type G9 in 1995. J. Clin. Microbiol. 37(6): 1885–1891.

 

Vainio K., S.A. Nordbø, G. Njølstad, G. Størvold. H. Døllner,C. Midgaard, F.J. Bosse, A.G. Rognlien, A. Rojahn, K.O. Wathne and others. 2009. Detection and characterization of group A RVAes in children hospitalized with acute gastroenteritis in Norway,2006–2008. J. Med. Virol. 81(10): 1839–1844.

 

Van Damme P., C. Giaquinto, M. Maxwell, P. Todd, M. Van der Wielen on behalf of the REVEAL Study Group. 2007. Distribu¬tion of RVA genotypes in Europe 2004–2005 the: REVEAL Study.J. Infect. Dis. 195(Suppl 1): S17–25.

 

van Zyl W.B., N.A. Page, W.O. Grabow, A.D. Steele and M.B. Tay¬lor. 2006. Molecular epidemiology of group A RVAes in water sources and selected raw vegetables in southern Africa. Appl. Envi¬ron. Microbiol. 72(7): 4554–4560.

 

Vizzi E., O. Piñeros, G.G. González, J.L. Zambrano, J.E. Ludert and F. Liprandi. 2011. Genotyping of human RVAes circulating among children with diarrhea in Valencia, Venezuela. J. Med. Virol. 83(12): 2225–2232.

 

Wobudeya E., H. Bachou, C.K. Karamagi, J.N. Kalyango, E. Mutebi, H. Wamani. 2011. Breastfeeding and the risk of RVA diarrhea in hospitalized infants in Uganda: a matched case control study. BMC Pediatrics. 11(17): 1–7

 

World Health Organization (WHO). 2009. RVA vaccines: an update. World Health Organization. Weekly Epidemiological Record. 84: 533–540.

 

EXTRA FILES

COMMENTS